Copy of Sublicenses and Sublicensee Royalty Reports. will submit to Stanford a copy of each Sublicense, any subsequent amendments and all copies of sublicensees’ royalty reports. Beginning with the first Sublicense, the Chief Financial Officer or equivalent will certify annually regarding the name and number of sublicensees.
Appears in 7 contracts
Samples: Exclusive (Equity) Agreement, Exclusive License Agreement, Exclusive License Agreement
Copy of Sublicenses and Sublicensee Royalty Reports. ImmuMetrix will submit to Stanford a copy of each Sublicense, any subsequent amendments and all copies of sublicensees’ royalty reports. Beginning with the first Sublicense, the Chief Financial Officer or equivalent will certify annually regarding the name and number of sublicensees.
Appears in 4 contracts
Samples: Merger Agreement (CareDx, Inc.), Exclusive Agreement (CareDx, Inc.), Merger Agreement (CareDx, Inc.)
Copy of Sublicenses and Sublicensee Royalty Reports. Medicenna will submit to Stanford a copy of each Sublicense, any subsequent amendments and all copies of sublicensees’ royalty reports. Beginning with the first Sublicense, the Chief Financial Officer or equivalent will certify annually regarding the name and number of sublicensees.
Appears in 3 contracts
Samples: Exclusive Equity Agreement (Medicenna Therapeutics Corp.), Exclusive Equity Agreement (Medicenna Therapeutics Corp.), Exclusive Equity Agreement
Copy of Sublicenses and Sublicensee Royalty Reports. Company will submit to Stanford a copy of each Sublicense, any subsequent amendments and all copies of sublicensees’ ' royalty reports. Beginning with the first Sublicense, the Chief Financial Officer or equivalent will certify annually regarding the name and number of sublicensees.
Appears in 3 contracts
Samples: Exclusive (Equity) Agreement (Ceribell, Inc.), Exclusive (Equity) Agreement (Ceribell, Inc.), Exclusive (Equity) Agreement (Ceribell, Inc.)
Copy of Sublicenses and Sublicensee Royalty Reports. Company will submit to Stanford a copy of each Sublicense, any subsequent amendments and all copies of sublicensees’ royalty reports. Beginning with the first Sublicense, the Chief Financial Officer or equivalent will certify annually regarding the name and number of sublicensees.
Appears in 2 contracts
Samples: Exclusive Agreement, Exclusive Agreement
Copy of Sublicenses and Sublicensee Royalty Reports. Epinomics will submit to Stanford a copy of each Sublicense, any subsequent amendments and all copies of sublicenseesSublicensees’ royalty reportsreports (each of which may be reasonably redacted to exclude confidential information that is not necessary for Stanford to enforce its payment rights or to confirm compliance under this Agreement). Beginning with the first Sublicense, the Chief Financial Officer or equivalent will certify annually regarding the name and number of sublicenseesSublicensees.
Appears in 2 contracts
Samples: Exclusive (Equity) Agreement (10x Genomics, Inc.), Exclusive (Equity) Agreement (10x Genomics, Inc.)
Copy of Sublicenses and Sublicensee Royalty Reports. LogicBio will submit to Stanford a copy of each Sublicense, any subsequent amendments and all copies of sublicensees’ royalty reports. Beginning with the first Sublicense, the Chief Financial Officer or equivalent will certify annually regarding the name and number of sublicensees.
Appears in 2 contracts
Samples: Exclusive (Equity) Agreement (LogicBio Therapeutics, Inc.), Exclusive (Equity) Agreement (LogicBio Therapeutics, Inc.)
Copy of Sublicenses and Sublicensee Royalty Reports. Selten will submit to Stanford a copy of each Sublicense, any subsequent amendments and all copies of sublicensees’ Sublicensees' royalty reports. Beginning with the first Sublicense, the Chief Financial Officer or equivalent will certify annually regarding the name and number of sublicenseesSublicensees.
Appears in 1 contract
Copy of Sublicenses and Sublicensee Royalty Reports. Purigen will submit to Stanford a copy of each Sublicense, any subsequent amendments and all copies of sublicensees’ ' royalty reports. Beginning with the first Sublicense, the Chief Financial Officer or equivalent will certify annually regarding the name and number of sublicensees.
Appears in 1 contract
Samples: Exclusive License Agreement (Bionano Genomics, Inc.)